MedTrace Logo

Lavender vs Zolpidem Sleep Quality During Diagnostic PSG

NCT04102345 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2021-03-17

Study results available
· View outcomes & findings →

Summary

In this pragmatic, clinical study the investigators propose that lavender aromatherapy is comparable to Zolpidem (Ambien) in improving the quality of diagnostic sleep studies.

Conditions

  • Sleep

Interventions

OTHER

Lavender Aromatherapy

Commercially available lavender essential oil and diffuser.

DRUG

Zolpidem

Physician directed, pre-prescribed. Study team does not prescribe zolpidem.

Sponsors & Collaborators

  • HealthPartners Institute

    lead OTHER

Principal Investigators

  • Charlene E McEvoy, MD, MPH · Medical Director, Regions Hospital/HealthPartners Sleep Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-04
Primary Completion
2020-11-10
Completion
2020-11-10
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04102345 on ClinicalTrials.gov